Iron deficiency anemia treatment with parenteral iron;Tratamento da anemia ferropriva com ferro por via parenteral

Revista Brasileira de Hematologia e Hemoterapia

Volumn 32, Issue SUPPL. 2, 2010, Pages 121-128

  Cançado, Rodolfo D ^a   Lobo, Clarisse ^a,b   Friedrich, João Ricardo ^a,c  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b Hemocentro do Rio de Janeiro Hemorio   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Anemia, iron deficiency; Ferric compounds; Ferrous compounds; Iron deficiency; Therapeutics

Indexed keywords

EID: 78649713496     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842010005000066     Document Type: Review

References (22)

1. Baynes RD. Iron deficiency. In: Brock JH, Halliday JW, Pippard MJ, Powell LW. Iron metabolism in health disease. London, W.B. Saunders, 1994. p.189-225.
2. Cook JD. Diagnosis and management of iron-deficiency anemia. Best Pract Res Clin Haematol. 2005;18(2):319-32.
3. Beutler E. Disorders of iron metabolism. In: Williams Hematology. Chapter 40. Seventh Edition. McGraw-Hill; 2006; 511-553.
4. Beris P, Maniatis A. Role of intravenous iron therapy in anemia management: state of the art. Semin Hematol 2006; 43(6):S1-S2.
5. Lyseng-Williamson KA, Keating G. Ferric carboxymaltose. A review of its use in iron-deficiency anaemia. Drugs. 2009;69 (6):739-56.
6. Anirban G, Kohli HS, Jha V, Gupta KL, Sakhuja V. The comparative safety of various intravenous iron preparations in chronic kidney disease patients. Ren Fail. 2008;30(6):629-38.
7. Geisser P. Safety and efficacy of iron(III)-hydroxide polymaltose complex. A review of over 25 years experience. Arzneimittelforschung. 2007;57(6A):439-52.
8. Toblli JE, Brignolli R. Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis. Arzneimittelforschung. 2007;57(6A):431-8.
9. Cançado RD et al. Avaliação da eficácia do uso intravenoso de sacarato de hidróxido de ferro III no tratamento de pacientes adultos com anemia ferropriva. Rev Bras Hematol Hemoter. 2007; 29:147-53.
10. Awerbach M, Goodnough LT, Picard D, Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion. 2008;48(5):988-1000.
11. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol. 2007;110(2 Pt 1):267-78.
12. Breymann C. The use of iron sucrose complex for anemia in pregnancy and the post partum period. Hematology. 2006;43 (6):S28-S31.
13. Gashe C, Kulnigg S. Intravenous iron in inflammatory bowel disease. Hematology. 2006;43(6):S18-S22.
14. Cuenca J, García-Erce JA, Martínez AA, Solano VM, Molina J, Muñoz M. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Arch Orthop Trauma Surg. 2005;125 (5):342-7.
15. Cuenca J, García-Erce JA, Martínez F, Pérez-Serrano L, Herrera A, Muñoz M. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion. 2006;46(7):1112-9.
16. Cuenca J, García-Erce JA, Muñoz M. Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery. Anesthesiology. 2008;109(1):151-2
17. García-Erce JA, Cuenca J, Muñoz M, Izuel M, Martínez AA, Herrera A, Solano VM, Martínez F. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang, 2005;88(4):235-43.
18. García-Erce JA, Cuenca J, Haman-Alcober S, Martínez AA, Herrera A, Muñoz M. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. Vox Sang. 2009;97(3):260-7.
19. Muñoz M, García-Erce JA, Cuenca J. Management of postoperative anemia after lower limb arthroplasty in patients over 65 years old. Anesth Analg. 2009;108(3):1045-6.
20. Love AL, Billett HH. Obesity, bariatric surgery, and iron deficiency: true, true, true and related. Am J Hematol. 2008;83(5):403-9.
21. Varma S, Baz W, Badine E, Nakhl F, McMullen H, Nicastro J et al. Need for parenteral iron therapy after bariatric surgery. Surg Obs Relat Dis. 2008;4(6):715-9.
22. Toblli JE, Cao G, Oliveri L, Angerosa M. Differences between original intravenous iron sucrose and iron sucrose similar preparations. Arzneimittelforschung. 2009;59(4):176-90.